Back
IDEXX Laboratories, Inc. (IDXX)
Health CareIDXX · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$563.53
+0.90%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$13.08
ROE
72.9%
Gross margin
62.1%
Debt/Equity
0.71x
Revenue growth
14.3%
IDEXX Laboratories, Inc. — company intelligence
Earnings surprises
Q1 2026$3.47 vs $3.47 est+0.1%
Q4 2025$3.08 vs $2.99 est+3.1%
Q3 2025$3.40 vs $3.19 est+6.5%
Q2 2025$3.63 vs $3.37 est+7.8%
Analyst consensus · 22 analysts
14 Buy8 Hold0 Sell
Updated Jul 6, 2026
Insider activity · 90 days
21 buys1 sellnet +6,833 shares
FENNELL GEORGESell 284 · Jun 1, 2026
FENNELL GEORGEother 639 · Jun 1, 2026
Claflin Bruce L.Buy 234 · May 12, 2026
Recent SEC filings
4 — Insider transaction reportJun 2, 2026
8-K — Material event reportMay 15, 2026
4 — Insider transaction reportMay 14, 2026
Latest news
IDEXX Laboratories to Release 2026 Second Quarter Financial Results — Yahoo · 1w ago
A Small Upgrade Could Have a Big Impact for IDEXX Customers — Yahoo · 2w ago
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years — Benzinga · 3w ago
Idexx (IDXX) Down 3.2% Since Last Earnings Report: Can It Rebound? — Yahoo · Jun 4, 2026
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About IDEXX Laboratories, Inc.
Weekly undervalued picks (like IDXX)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.